Hebei Guanlang Biotechnology Co., Ltd.
     --Chinese leading pharmaceutical intermediates customized manufacturer
Location:Home >> Pharmaceutical Raw Materials
product name
【 Orlistat Powder|96829-58-2|Guanlang Group 】


Orlistat (CAS NO.96829-58-2) is a drug designed to treat obesity. It is mainly used for preventing the absorption of fats from the human diet, thereby reducing caloric intake. Besides, it is intended for use in conjunction with a physician-supervised reduced-calorie diet.


Item

Requirements

Test Results

Appearance

while to off-while powder

White powder

Identification

HPLC retention time

Conforms

Melting Point

42 ºC -45°C

42°C-44°C

Specific optical rotation

-31.0°~-41.0°

-36.0°

Purity by HPLC

no less than 98.0%

98.5%

Total impurity

no more than 2.0%

1.6%

Max Individual impurity

no more than 0.5%

0.3%

Water content%(K&F)

no more than 0.5%

0.1%

Residual solvents

EtOH no more than 0.5%

N.D

EtAC no more than 0.5%

N.D

n-Heptane no more than 0.5%

less than 0.1%

Residue on ignition

less than 0.2%

0.10%

Heavy metals as Pb

no more than 20ppm

less than20ppm

Assay (HPLC)

no less than 98.0%

99.60%

Conclusion

Meets the Requirements


Orlistat is an internationally recognized new form of weight loss drug. Its commercial name is Sainike and first went on sale in New Zealand in 1998. Orlistat is a long-term and highly effective specific gastrointestinal lipase inhibitor, and it is insoluble in water, soluble in chloroform, and easily soluble in ethanol.
Orlistat can be used clinically to treat obesity. Usually, a dose of 120mg is taken three times a day within one hour of a meal. Weight loss begins to occur after two weeks of usage. It can be used continuously for 6-12 months, and its effects will cease to increase after daily dosage exceeds 400mg. This drug is suitable to be used in combination with a low-calorie diet by obese and overweight individuals, and it can also be used as long-term treatment for patients who have faced weight-related risk factors. Orlistat has a long-term weight-control effect that reduces and maintains weight and prevents against rebounding. Using Orlistat can lower the occurrences of weight-related risk factors and diseases, including hypercholesterolemia, type-2 diabetes, impaired glucose tolerance, hyperinsulinemia, and hypertension, and it can reduce the fat content in organs. Orlistat also adjusts blood lipid levels: it can decrease serum triglycerides (TG) and low density lipoprotein cholesterol (LDL-C), and it can increase the ratio of high density lipoproteins to low density lipoproteins in obese patients.

PRODUCTS
Pharmaceutical Intermediates
Organic Chemicals
Pharmaceutical Raw Materials
Best Sellers
Copyright © Hebei Guanlang Biotechnology Co., Ltd.